Published in Virology on June 01, 1982
DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain. J Virol (1986) 2.89
Interaction of minute virus of mice with differentiated cells: strain-dependent target cell specificity is mediated by intracellular factors. J Virol (1983) 2.44
Host range transforming gene of polyoma virus plays a role in virus assembly. Proc Natl Acad Sci U S A (1983) 1.69
A polyoma mutant that encodes small T antigen but not middle T antigen demonstrates uncoupling of cell surface and cytoskeletal changes associated with cell transformation. Mol Cell Biol (1984) 1.52
Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell (1997) 8.28
Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet (1991) 6.61
Structure of simian virus 40 at 3.8-A resolution. Nature (1991) 5.96
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell (1997) 5.92
Host range mutants of polyoma virus. Proc Natl Acad Sci U S A (1970) 5.68
Tumor antigen(s) in cell productively infected by wild-type polyoma virus and mutant NG-18. Proc Natl Acad Sci U S A (1978) 4.64
Localization of gene functions in polyoma virus DNA. Proc Natl Acad Sci U S A (1976) 4.38
Phosphorylation of polyoma T antigens. Cell (1979) 3.94
Virus-specific RNA in cells productively infected or transformed by polyoma virus. J Mol Biol (1966) 3.92
Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature (1994) 3.35
Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation. Proc Natl Acad Sci U S A (1982) 3.12
Comparison of phosphorylation of two polyoma virus middle T antigens in vivo and in vitro. J Virol (1981) 2.85
Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol (1987) 2.84
Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis. Cell (1989) 2.71
Host range selection of transformation-defective hr-t mutants of polyoma virus. Virology (1977) 2.68
PML induces a novel caspase-independent death process. Nat Genet (1998) 2.66
Comparisons of two early gene functions essential for transformation in polyoma virus and SV-40. Virology (1979) 2.64
Deficiency in histone acetylation in nontransforming host range mutants of polyoma virus. Proc Natl Acad Sci U S A (1976) 2.37
P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer (2000) 2.35
Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet (1993) 2.33
Relative target sizes for the inactivation of the transforming and reproductive abilities of polyoma virus. Proc Natl Acad Sci U S A (1965) 2.32
Hr-t and ts-a: two early gene functions of polyoma virus. Virology (1977) 2.28
Nucleotide sequence deletions within the coding region for small-t antigen of simian virus 40. J Virol (1979) 2.23
Analysis of host range of nontransforming polyoma virus mutants. Virology (1975) 2.18
Cellular alterations dependent upon the polyoma virus Hr-t function: separation of mitogenic from transforming capacities. Cell (1978) 2.05
Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts. Mol Cell Biol (1985) 1.94
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med (1993) 1.91
Viable deletion mutants in the simian virus 40 early region. Proc Natl Acad Sci U S A (1978) 1.89
Identification of DNA sequence changes leading to loss of transforming ability in polyoma virus. J Biol Chem (1980) 1.89
Location of BRCA1 in human breast and ovarian cancer cells. Science (1996) 1.88
Polyoma virus middle T antigen: relationship to cell membranes and apparent lack of ATP-binding activity. Mol Cell Biol (1982) 1.87
Immortalization of rodent embryo fibroblasts by SV40 is maintained by the A gene. Virology (1983) 1.87
Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet (1997) 1.84
Polyomavirus replication in mice: influences of VP1 type and route of inoculation. J Virol (1991) 1.79
Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet (2001) 1.77
A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior. J Virol (1991) 1.77
Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc Natl Acad Sci U S A (1984) 1.71
Host range transforming gene of polyoma virus plays a role in virus assembly. Proc Natl Acad Sci U S A (1983) 1.69
Phosphatidylinositol 3-phosphate is present in normal and transformed fibroblasts and is resistant to hydrolysis by bovine brain phospholipase C II. J Biol Chem (1989) 1.67
Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen. J Virol (1991) 1.66
Polyomavirus tumor induction in mice: influences of viral coding and noncoding sequences on tumor profiles. J Virol (1987) 1.65
Early steps of polyomavirus entry into cells. J Virol (2000) 1.64
DNA sequence alterations in Hr-t deletion mutants of polyoma virus. Cell (1979) 1.56
A polyoma mutant that encodes small T antigen but not middle T antigen demonstrates uncoupling of cell surface and cytoskeletal changes associated with cell transformation. Mol Cell Biol (1984) 1.52
Genetic and structural analysis of a virulence determinant in polyomavirus VP1. J Virol (1995) 1.52
Virion assembly defect of polyomavirus hr-t mutants: underphosphorylation of major capsid protein VP1 before viral DNA encapsidation. J Virol (1985) 1.50
A new member of the polyomavirus family: the hamster papovavirus. Complete nucleotide sequence and transformation properties. EMBO J (1985) 1.50
A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res (1997) 1.49
Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse. J Virol (1999) 1.47
Absence of a cell membrane alteration function in non-transforming mutants of polyoma virus. Proc Natl Acad Sci U S A (1970) 1.47
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet (1996) 1.45
Antibody to the nonapeptide Glu-Glu-Glu-Glu-Tyr-Met-Pro-Met-Glu is specific for polyoma middle T antigen and inhibits in vitro kinase activity. J Biol Chem (1982) 1.37
ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data. Genet Epidemiol (1995) 1.37
Study of the maturation of 5 s RNA precursors in Escherichia coli. J Mol Biol (1972) 1.37
BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res (2000) 1.36
Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med (1995) 1.33
Expression of polyoma early gene products in E. coli. Nucleic Acids Res (1985) 1.29
The hr-t gene of polyoma virus. Biochim Biophys Acta (1982) 1.28
Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice. J Virol (1988) 1.27
A ribonuclease-resistant region of 5S RNA and its relation to the RNA binding sites of proteins L18 and L25. Nucleic Acids Res (1979) 1.22
Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA. Hum Mol Genet (1993) 1.19
Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen. J Virol (1998) 1.18
Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product. Oncogene (1992) 1.15
Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am J Pathol (1992) 1.15
Heterogeneity in state and expression of viral DNA in polyoma virus-induced tumors of the mouse. Virology (1992) 1.13
Isolation and characterization of polyoma nucleoprotein complexes. Virology (1983) 1.12
Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer. Cold Spring Harb Symp Quant Biol (2005) 1.10
Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene (1999) 1.07
Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells. Oncogene (1998) 1.06
Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells. Kidney Int (1991) 1.04
Separation of host range from transformation functions of the hr-t gene of polyomavirus. Virology (1989) 1.04
A Thermosensitive mutant defective in ribosomal 30 S subunit assembly. FEBS Lett (1971) 1.03
Radiation-resistant and radiation-sensitive forms of host resistance to polyomavirus. J Virol (1999) 1.02
A tumor host range selection procedure identifies p150(sal2) as a target of polyoma virus large T antigen. Proc Natl Acad Sci U S A (2001) 1.02
Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase. Mol Cell Biol (1996) 1.02
Phosphorylation pattern of large T antigens in mouse cells infected by simian virus 40 wild type or deletion mutants. J Virol (1982) 1.01
Mutant carrying deletions in the two simian virus 40 early genes. J Virol (1981) 1.00
Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Proc Natl Acad Sci U S A (1997) 1.00
The middle T proteins of high and low tumor strains of polyomavirus function equivalently in tumor induction. Virology (1988) 1.00
Induction of lymphomas by the hamster papovavirus correlates with massive replication of nonrandomly deleted extrachromosomal viral genomes. J Virol (1987) 0.99
Stable cell lines of T-SV40 immortalized human glomerular mesangial cells. Kidney Int (1996) 0.99
Indirect complementation of a nontransforming mutant of polyoma virus. Cold Spring Harb Symp Quant Biol (1975) 0.99
Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology (1992) 0.98
Abnormal maturation of precursor 16S RNA in a ribosomal assembly defective mutant of E. coli. Nucleic Acids Res (1974) 0.98
The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to EDH17B2 in chromosome region 17q12-q21. Hum Mol Genet (1994) 0.96
p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome. Oncogene (1999) 0.96
Identification and characterization of the hamster polyomavirus middle T antigen. J Virol (1991) 0.96
Ribosomal assembly defective mutants of Escherichia coli. Nucleic Acids Res (1974) 0.95
Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies. Clin Chim Acta (1997) 0.95
The hamster polyomavirus--a brief review of recent knowledge. Virus Genes (2001) 0.95
Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci U S A (1994) 0.95
Accelerated development of polyoma tumors and embryonic lethality: different effects of p53 loss on related mouse backgrounds. Cell Growth Differ (2000) 0.94
Pyvs: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus. Virology (1993) 0.94
Host range and cell cycle activation properties of polyomavirus large T-antigen mutants defective in pRB binding. J Virol (1994) 0.93
The hr-t gene of polyoma virus. Cold Spring Harb Symp Quant Biol (1980) 0.93
5 S RNA and the assembly of bacterial ribosomes. Cold Spring Harb Symp Quant Biol (1969) 0.93
Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene (1996) 0.92
Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene (1997) 0.92